Machine Learning‐Driven Discovery of GABA‐A Ligands with Pronounced Neuroprotective Efficacy and Resistance to P‐gp Efflux
ChemMedChem · 2026
DOI: 10.1002/cmdc.202500605 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Katarzyna Szafrańska und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, Krakow, 30-688, Poland. Hauptthemen laut MEDLINE: Machine Learning, Neuroprotective Agents, Receptors, GABA-A, ATP Binding Cassette Transporter, Subfamily B, Member 1. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Narodowe Centrum Nauki, Jagiellonian University Medical College.
Abstract (Originalsprache)
Many studies have pointed to GABA‐A receptors as a promising therapeutic target for promoting recovery after stroke, owing to their neuroprotective efficacy and the enhancement of synaptic GABAergic currents. However, identifying nanomolar‐affinity ligands that evade P‐glycoprotein–mediated efflux can pose a significant challenge. To overcome this barrier, we developed a structure‐based machine learning workflow integrating molecular docking, which screened over 160 000 virtual analogs and identified eight synthetically accessible molecules. The synthesized compounds exhibited K i values at the GABA‐A receptor ranging from 50 to 1600 nM, with the most promising being 4d ( K i = 62 ± 11 nM) and 4h ( K i = 50 ± 3 nM), both of which confirmed PAM efficacy at GABA‐A receptors. Both ligands exhibited neuroprotective activity by attenuating glutamate‐induced Ca 2+ overload, preserving mitochondrial membrane potential and enhancing cell viability following oxygen–glucose deprivation in HT‐22 neurons. In MDR1‐MDCKII bidirectional assays, compound 4d (azetidine derivative) exhibited symmetric permeability (efflux ratio = 0.94), while 4h (bicyclic amino alcohol) was identified as a P‐gp substrate (efflux ratio = 2.04), suggesting that eliminating a single hydrogen‐bond donor at the amide tail is critical for minimizing efflux. Collectively, this study identifies compound 4d as a potent, low‐efflux GABA‐A receptor PAM with neuroprotective properties, supporting its further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, Krakow, 30-688, Poland.
- Department of Pharmacobiology, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, Krakow, 30-688, Poland.
ORCID-Profile: Monika Marcinkowska
Förderung
- Narodowe Centrum Nauki
- Jagiellonian University Medical College
Zitieren
APA
Szafrańska, K., Koch, K., Jończyk, J., Mordyl, B., Głuch-Lutwin, M., Wojdyła, B., Krzysztofik, D., Siwek, A., Wolak, M., Więckowski, K., Kołaczkowski, M., & Marcinkowska, M. (2026). Machine Learning‐Driven Discovery of GABA‐A Ligands with Pronounced Neuroprotective Efficacy and Resistance to P‐gp Efflux. ChemMedChem. https://doi.org/10.1002/cmdc.202500605
Vancouver
Szafrańska K, Koch K, Jończyk J, Mordyl B, Głuch-Lutwin M, Wojdyła B, et al. Machine Learning‐Driven Discovery of GABA‐A Ligands with Pronounced Neuroprotective Efficacy and Resistance to P‐gp Efflux. ChemMedChem. 2026. doi:10.1002/cmdc.202500605
BibTeX
@article{Szafraska2026,
author = {Szafrańska, Katarzyna and Koch, Konstantin and Jończyk, Jakub and Mordyl, Barbara and Głuch-Lutwin, Monika and Wojdyła, Bartosz and Krzysztofik, Dominika and Siwek, Agata and Wolak, Małgorzata and Więckowski, Krzysztof and Kołaczkowski, Marcin and Marcinkowska, Monika},
title = {Machine Learning‐Driven Discovery of GABA‐A Ligands with Pronounced Neuroprotective Efficacy and Resistance to P‐gp Efflux},
journal = {ChemMedChem},
year = {2026},
doi = {10.1002/cmdc.202500605}
}
EUVIMED